Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2019 on request of the sponsor.

On 16 December 2014, orphan designation (EU/3/14/1405) was granted by the European Commission to TxCell, France, for autologous collagen type II-specific regulatory T cells for the treatment of non-infectious uveitis.

Key facts

Active substance
Autologous collagen type II-specific regulatory T cells
Disease / condition
Treatment of non-infectious uveitis
Date of first decision
EU designation number

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

Allée de la Nertière - Les Cardoulines
06560 Valbonne - Sophia Antipolis
Tel. +33 497 21 83 01
Fax +33 493 64 15 80

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating